Global Controlled Release Drug Delivery Market is expected to reach USD 90.18 billion by 2025. Controlled drug delivery system is a system that carries the drug at a programmed rate, for systemically or locally, for a definite period. Controlled release drug delivery employs drug-encapsulating devices from that therapeutic agent might be released at measured rates for long periods, extending from days to months.
These systems offer many benefits over traditional methods of drug delivery, comprises increased patient comfort and compliance, tailoring of drug release rates, and protection of fragile drugs. The controlled release drug delivery market is estimated to grow at a significant CAGR of 13.8% over the future period as the scope and its applications are rising enormously across the globe. Controlled release drug delivery market is segmented based on technology, mechanism, application, and region.
Download Free Sample Report @ https://www.millioninsights.com/industry-reports/controlled-release-drug-delivery-market/request-sample
Highly enhanced technology used includes Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation, and others that could be explored in controlled release drug delivery market in the future period. Targeted delivery sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years. However, micro encapsulation sector is estimated to grow at fastest pace in the coming years.
Chemically Activated, Polymer Matrix Based Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Feedback Regulated Drug Delivery Systems are the release mechanisms that could be explored in controlled release drug delivery market in the forecast period. Chemically activated sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years. The sector consists of enzyme-responsive solutions, pH-activated, and hydrolysis of activated solutions. Also, polymer matrix based system sector is estimated to grow at fastest pace with significant market share in the foremost period.
The market may be categorized based on applications like Drug Eluting Stents, Metered Dose Inhalers, Oral Controlled-Drug Delivery Systems, Injectable, Infusion Pumps, Transdermal and Ocular Patches, and others. Oral Controlled-Drug Delivery Systems accounted for the largest market share and is estimated to continue its dominance by 2025. This may be because of easy availability and high usage, growth in use of generic medications, and highly preferred over conventional forms. Also, metered dose inhalers sector is estimated to grow at fastest pace in the coming years.
Globally, North America accounted for the largest market share of controlled release drug delivery in terms of revenue and is estimated to lead the overall market in the upcoming years. The reason behind the overall market growth could be rising demand for these systems, government initiative for expansion of precise release drug delivery, presence of key manufacturers in the region, and rising investments in research and development sector.
Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise, rising expansion in pharmaceutical industry, growing research and development sectors, high investment from multinational industries, and growing market opportunities in the region.
The key players of controlled release drug delivery industry are Aradigm Corporation, Depomed, Inc., Capsugel; Merck and Co., Inc., Coating Place, Inc., Orbis Biosciences, Inc., Corium International, Inc., Pfizer, Inc., Johnson and Johnson, and Alkermes plc. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
Controlled Release Drug Delivery Technology Outlook (Revenue, USD Billion, 2014 - 2025)
- Wurster Technique
- Coacervation
- Microencapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
Controlled Release Drug Delivery Release Mechanism Outlook (Revenue, USD Billion, 2014 - 2025)
- Polymer Matrix Based Systems
- Micro Reservoir Partition Controlled Drug Delivery Systems
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Chemically Activated
Controlled Release Drug Delivery Application Outlook (Revenue, USD Billion, 2014 - 2025)
- Metered Dose Inhalers
- Injectable
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
- Drug Eluting Stents
Continued…
Global Controlled Release Drug Delivery Market is expected to reach USD 90.18 billion by 2025.
The controlled release drug delivery market is estimated to grow at a significant CAGR of 13.8% over the future period as the scope and its applications are rising enormously across the globe.
Controlled release drug delivery market is segmented based on technology, mechanism, application, and region.Highly enhanced technology used includes Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation, and others that could be explored in controlled release drug delivery market in the future period.
Targeted delivery sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
However, micro encapsulation sector is estimated to grow at fastest pace in the coming years.Chemically Activated, Polymer Matrix Based Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Feedback Regulated Drug Delivery Systems are the release mechanisms that could be explored in controlled release drug delivery market in the forecast period.
Chemically activated sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
Global Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2023Controlled release drug delivery is a method of doling out drugs in required doses to patients.
Market Research Future (MRFR) has compiled the topmost trends, opportunities, and growth drivers of the global controlled release drug delivery market report with forecasts for the period between 2017 and 2023.Controlled Release Drug Delivery Market OutlookThe Global Advanced Controlled Release Drug Delivery Market is set to achieve a jump in valuation from USD 31.96 billion in 2017 to USD 70.15 billion by 2023, according to MRFR.
Key factors driving market growth include rising cases of patient deaths due to overdose, health problems from high doses, and rising R efforts in the healthcare industry.
Advantages pertaining to the technology such as reduction of toxin accumulation, acclimatization of patients to the dose rate, and stability of the medical condition can influence the controlled drug delivery market demand.Low awareness of the technology and high costs per dose can negatively impact the market growth trajectory.Controlled Release Drug Delivery Market Competitive LandscapeAllergan, SKY Pharmaceuticals Pvt.
Ltd., Alza Corporation (Johnson & Johnson), Novartis, Depomed, Inc. (US), AstraZeneca, Collegium Pharmaceutical, GlaxoSmithKline, Pfizer Inc., Corium International Inc., Coating Place, Inc., Biogen, and others are key market participants.Controlled Release Drug Delivery Market SegmentationThe global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end users.By route of administration the market is segmented into nasal, oral, ocular, topical, implantable, and injectable.
The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal.On the basis of the release mechanism, the market is segmented into activation modulated drug delivery systems, polymer-based drug delivery systems, feedback-regulated drug delivery systems, micro-reservoir partition-controlled drug delivery systems, and chemically activated controlled drug delivery systems.
